Study objectives: Patients with pulmonary arterial hypertension (PAH) often present with
dyspnea and severe functional limitations, but their health-related quality of life (HRQOL) …

It is well established that pulmonary hypertension (PH) places a substantial burden on
patients' health-related quality of life (HRQoL). As more effective treatments have been …

Limited studies have focused on mental symptoms (anxiety and depression) and their
impact on quality of life (QoL) in patients with pulmonary hypertension (PH). The objective of …

Background The study investigated the level of mental distress in patients with pulmonary
hypertension (PH) and assessed the use of and the wish for psychosomatic treatment …

Background Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary
hypertension (CTEPH) are life-threatening diseases with a high burden of symptoms …

Background The purpose of the study was to examine pulmonary hypertension (PH)
patients' quality of life (QOL) for the first time in Finland. Methods This was a non …

Introduction Mental disorders are common in patients with pulmonary arterial hypertension
(PAH) and contribute to impaired quality of life (QoL). The impact of mental disorders on …

Objectives: Pulmonary arterial hypertension and chronic thromboembolic pulmonary
hypertension are severe diseases with complicated treatment that need care at specialist …

Background The causal association between depression, anxiety, and health-related quality
of life (HRQoL) in chronic obstructive pulmonary disease (COPD) is unclear. We therefore …

Background Pulmonary arterial hypertension (PAH) is an uncommon condition with
progressive heart failure and premature death. Treatment costs up to£ 120,000 per patient …